Trial intelligence / Profile preview

Collagenase Santyl in Diabetic Foot Ulcers

NCT01197898Phase 4Completed

Sponsor
Healthpoint Biotherapeutics
Start
Dec 2010
Primary completion
Apr 2012
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 4 trial of collagenase in diabetic foot ulcer (DFU), sponsored by Healthpoint Biotherapeutics. Started Dec 2010; status: completed.

02

Drugs

collagenase
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NCT01197898.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01197898.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call